Understanding the Toxicity Profile of Approved ADCs by Pablo Ballestín, Alfonso López de Sá, Cristina Díaz-Tejeiro, Lucía Paniagua-Herranz, Adrián Sanvicente, Igor López-Cade, Pedro Pérez-Segura, Carlos Alonso-Moreno, Cristina Nieto-Jiménez, Alberto Ocaña

Subjects: “…antibody–drug conjugate…”
Get full text

Antibody drug conjugates by Stalin Bala, Siva K Prasad

Subjects: “…antibody drug conjugate…”
Get full text

Datopotamab deruxtecan induces hallmarks of immunogenic cell death by Sabrina Forveille, Marion Leduc, Allan Sauvat, Guido Kroemer, Oliver Kepp

Subjects: Get full text

Patritumab deruxtecan induces immunogenic cell death by Sabrina Forveille, Liwei Zhao, Allan Sauvat, Giulia Cerrato, Marion Leduc, Flora Doffe, Yuhong Pan, Peng Liu, Guido Kroemer, Oliver Kepp

Subjects: “…Antibody drug conjugate…”
Get full text

The Antibody Drug Conjugate, Belantamab-Mafodotin, in the Treatment of Multiple Myeloma: A Comprehensive Review by Almodovar Diaz AA, Alouch SS, Chawla Y, Gonsalves WI

Subjects: Get full text

Clinical advances in antibody-drug conjugates for hematological malignancies by TANG Sijie, MI Jianqing

Subjects: “…antibody-drug conjugate (adc)…”
Get full text

Preliminary biological evaluation of 123I-labelled anti-CD30-LDM in CD30-positive lymphomas murine models by Jianhua Gong, Feihu Guo, Weihua Cheng, Hongqiang Fan, Qingfang Miao, Jigang Yang

Subjects: Get full text

The ideal strategies of antibody‒drug conjugate sequential treatment in HER2-expressing metastatic breast cancer: A multi-center real-world study by Xuenan Peng, Bo Lan, Jiayu Wang, Qiao Li, Jiani Wang, Ying Fan, Yang Luo, Shanshan Chen, Hongnan Mo, Lixi Li, Xiaoying Sun, Jintao Zhang, Ruigang Cai, Pin Zhang, Binghe Xu, Fei Ma

Subjects: Get full text

An Anti‐CD147 Antibody−Drug Conjugate Mehozumab‐DM1 is Efficacious Against Hepatocellular Carcinoma in Cynomolgus Monkey by Wan Huang, Liping Zhong, Ying Shi, Qingzhi Ma, Xiangmin Yang, Hongmei Zhang, Jing Zhang, Ling Wang, Kun Wang, Jingzhuo Li, Jie Zou, Xu Yang, Liu Yang, Qingmei Zeng, Lin Jing, Zhi‐Nan Chen, Yongxiang Zhao

Subjects: “…antibody‐drug conjugate…”
Get full text

Electrostatic properties of human germlines and biodistribution of small biologics by Leticia Maria De Souza Cordeiro, Kelley Christine Atkinson, Argin Aivazian, Patrick Frank Joyce, Fang Jia, Alessandro Mascioni

Subjects: Get full text

Antibody drug conjugates in the clinic by Edidiong Udofa, Disha Sankholkar, Samir Mitragotri, Zongmin Zhao

Subjects: Get full text

The efficacy of trastuzumab deruxtecan in Chinese breast cancer patients: a real-world multicenter study by Miao He, Miao He, Xiaohui Liu, Yan Zhang, Zhenyu Shao, Tiantian Sun, Yu Hu

Subjects: Get full text

Design, Development, and Antitumor Potential of CD228-Targeted Antibody–Drug Conjugates by Haitao Qiu, Liping Xie

Subjects: Get full text

Emerging technology trends in regulatory approvals of cancer immunotherapy drugs by the FDA and EMA by Maryam Monajati, Alimohammad Tamaddon, Samira Sadat Abolmaali

Subjects: Get full text

Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and R... by Catherine C. Fahey, Sean Clark-Garvey, Sima Porten, Ashish M. Kamat, Thomas W. Flaig, John A. Taylor, William Y. Kim, Matthew I. Milowsky

Subjects: Get full text

Key considerations based on pharmacokinetic/pharmacodynamic in the design of antibody-drug conjugates by Yangyang Gao, Yuwei Xia, Yixin Chen, Shiqi Zhou, Yingying Fang, Jieru Yu, Leyin Zhang, Leyin Zhang, Leitao Sun, Leitao Sun, Leitao Sun

Subjects: “…antibody-drug conjugate…”
Get full text

Development of a bispecific antibody–drug conjugate targeting EpCAM and CLDN3 for the treatment of multiple solid tumors by Meiying Luo, Xiaohuan Wang, Guoji Yu, Jing Ji, Long Li, Fan Song

Subjects: Get full text

Homogeneous antibody-drug conjugates with dual payloads: potential, methods and considerations by Miao Wen, Abigail Yu, Young Park, Daniel Calarese, Hans-Peter Gerber, Gang Yin

Subjects: “…Antibody drug conjugate…”
Get full text

Establishing a comprehensive panel of patient-derived xenograft models for high-grade endometrial carcinoma: molecular subtypes, genetic alterations, and therapeutic target profili... by Sho Sato, Shigehiro Yagishita, Hiroshi Yoshida, Daisuke Shintani, Aiko Ogasawara, Tadaaki Nishikawa, Masanori Yasuda, Keiji Furuuchi, Toshimitsu Uenaka, Akinobu Hamada, Kosei Hasegawa

Subjects: Get full text

Preclinical pharmacokinetics, distribution, metabolism and excretion of disitamab vedotin by Ling Wang, Limeng Zhu, Fengzhu Wang, Lihou Dong, Zhihao Liu, Fang Chen, Jing Jiang

Subjects: “…Antibody-drug conjugate…”
Get full text